Meclon (Clotrimazole, Metronidazole)

Clotrimazole inhibits the fungal enzyme lanosterol 14α‑demethylase, blocking ergosterol synthesis and disrupting the cell membrane of Candida species. Metronidazole is reduced inside anaerobic bacteria to reactive nitro radicals that damage DNA and inhibit nucleic acid synthesis, leading to bacterial cell death. Together they provide broad‑spectrum activity against both yeast and anaerobic bacteria.

The dosage regimen for Meclon is determined by the prescribing healthcare professional based on the specific infection, severity, and patient factors. Patients should follow the exact instructions provided on the prescription label and by their clinician.

Safety data for Meclon in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing to pregnant or nursing women. Women should discuss their individual situation with a qualified professional.

To request Meclon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with single‑agent products, Meclon offers a dual mechanism that simultaneously targets fungal and anaerobic bacterial pathogens, making it suitable for mixed infections. Alternatives may require separate antifungal and antibacterial treatments, potentially increasing cost and complexity of therapy.

Meclon should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiration date.

Meclon is applied intravaginally as directed by a healthcare professional. The patient typically inserts the prescribed amount into the vagina using the supplied applicator or as instructed, and remains lying down for a short period to ensure proper distribution.

Serious risks include severe allergic reactions such as rash, swelling, or anaphylaxis, as well as rare but serious conditions like Stevens‑Johnson syndrome, severe vaginal ulceration, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience any of these symptoms.

Meclon should not be used by individuals with a known hypersensitivity to clotrimazole, metronidazole, or any formulation excipients. It is also contraindicated in the presence of active vaginal ulceration or severe inflammation until the underlying condition is resolved.